QIAGEN Return on Investment 2010-2023 | QGEN
Current and historical return on investment (ROI) values for QIAGEN (QGEN) over the last 10 years.
| QIAGEN ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2023-03-31 |
$0.42B |
$5.05B |
8.66% |
| 2022-12-31 |
$0.53B |
$4.94B |
11.10% |
| 2022-09-30 |
$0.60B |
$4.75B |
13.03% |
| 2022-06-30 |
$0.63B |
$4.76B |
13.90% |
| 2022-03-31 |
$0.67B |
$4.72B |
14.63% |
| 2021-12-31 |
$0.63B |
$4.19B |
13.64% |
| 2021-09-30 |
$0.61B |
$4.58B |
12.93% |
| 2021-06-30 |
$0.53B |
$4.92B |
11.37% |
| 2021-03-31 |
$0.48B |
$4.78B |
11.00% |
| 2020-12-31 |
$0.39B |
$4.68B |
9.27% |
| 2020-09-30 |
$0.31B |
$4.13B |
7.78% |
| 2020-06-30 |
$0.06B |
$4.02B |
1.47% |
| 2020-03-31 |
$0.00B |
$3.88B |
0.00% |
| 2019-12-31 |
$-0.03B |
$3.96B |
-0.64% |
| 2019-09-30 |
$-0.02B |
$4.16B |
-0.44% |
| 2019-06-30 |
$0.27B |
$4.04B |
6.67% |
| 2019-03-31 |
$0.26B |
$4.00B |
6.57% |
| 2018-12-31 |
$0.27B |
$4.31B |
6.78% |
| 2018-09-30 |
$0.22B |
$3.59B |
5.63% |
| 2018-06-30 |
$0.21B |
$3.87B |
5.07% |
| 2018-03-31 |
$0.18B |
$3.94B |
4.31% |
| 2017-12-31 |
$0.15B |
$4.30B |
3.82% |
| 2017-09-30 |
$0.11B |
$4.31B |
2.97% |
| 2017-06-30 |
$0.10B |
$3.89B |
2.65% |
| 2017-03-31 |
$0.11B |
$3.50B |
2.90% |
| 2016-12-31 |
$0.10B |
$3.67B |
2.68% |
| 2016-09-30 |
$0.15B |
$3.74B |
4.15% |
| 2016-06-30 |
$0.15B |
$3.70B |
4.14% |
| 2016-03-31 |
$0.16B |
$3.68B |
4.45% |
| 2015-12-31 |
$0.18B |
$3.62B |
5.00% |
| 2015-09-30 |
$0.14B |
$3.58B |
3.95% |
| 2015-06-30 |
$0.15B |
$3.59B |
4.01% |
| 2015-03-31 |
$0.15B |
$3.53B |
4.13% |
| 2014-12-31 |
$0.16B |
$3.70B |
4.21% |
| 2014-09-30 |
$0.17B |
$3.75B |
4.59% |
| 2014-06-30 |
$0.16B |
$3.93B |
4.23% |
| 2014-03-31 |
$0.08B |
$3.90B |
2.11% |
| 2013-12-31 |
$0.06B |
$3.57B |
1.79% |
| 2013-09-30 |
$0.08B |
$3.52B |
2.22% |
| 2013-06-30 |
$0.08B |
$3.44B |
2.42% |
| 2013-03-31 |
$0.16B |
$3.54B |
4.85% |
| 2012-12-31 |
$0.17B |
$3.57B |
5.24% |
| 2012-09-30 |
$0.10B |
$3.16B |
3.24% |
| 2012-06-30 |
$0.10B |
$3.09B |
3.11% |
| 2012-03-31 |
$0.10B |
$3.08B |
3.07% |
| 2011-12-31 |
$0.10B |
$3.00B |
3.07% |
| 2011-09-30 |
$0.17B |
$3.03B |
5.19% |
| 2011-06-30 |
$0.19B |
$3.39B |
5.58% |
| 2011-03-31 |
$0.18B |
$3.33B |
5.56% |
| 2010-12-31 |
$0.19B |
$3.27B |
5.83% |
| 2010-09-30 |
$0.17B |
$3.25B |
5.37% |
| 2010-06-30 |
$0.18B |
$3.23B |
5.52% |
| 2010-03-31 |
$0.18B |
$3.21B |
6.13% |
| 2009-12-31 |
$0.18B |
$3.19B |
6.42% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.436B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
